| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |